Putnam Investments’s Kite Pharma, Inc. KITE Stock Holding History

Putnam Investments’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-20,161	Closed	-$1.58M	–	1406
2017 Q1	$1.58M	Sell	20,161 -2,836	-12%	-$175K	﹤0.01%	910
2016 Q4	$1.03M	Buy	+22,997	New	+$1.13M	﹤0.01%	1001
2016 Q3	–	Sell	-46,550	Closed	-$2.33M	–	1404
2016 Q2	$2.33M	Hold	46,550	–	–	0.01%	881
2016 Q1	$2.14M	Hold	46,550	–	–	0.01%	934
2015 Q4	$2.87M	Hold	46,550	–	–	0.01%	879
2015 Q3	$2.59M	Hold	46,550	–	–	0.01%	918
2015 Q2	$2.84M	Hold	46,550	–	–	0.01%	950
2015 Q1	$2.69M	Hold	46,550	–	–	0.01%	958
2014 Q4	$2.69M	Hold	46,550	–	–	0.01%	943
2014 Q3	$1.33M	Buy	+46,550	New	+$1.15M	﹤0.01%	1144

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Putnam Investments's KITE Position: Q2 2017 in Review

Putnam Investments sold out of Kite Pharma, Inc. (KITE) in Q2 2017, closing a stake of 20,161 shares — an estimated $1.58M sold.

Putnam Investments first reported a position in KITE in Q3 2014 and held it in 10 quarters. The position peaked at $2.87M in Q4 2015. 220 funds tracked by Wall St. Rank hold KITE as of Q2 2017.

Putnam Investments reported no remaining Kite Pharma, Inc. position as of Q2 2017 after selling out during the quarter.
Putnam Investments sold 20,161 Kite Pharma, Inc. shares in Q2 2017, an estimated $1.58M.
Putnam Investments first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 10 quarters.
Putnam Investments's Kite Pharma, Inc. position peaked at $2.87M in Q4 2015.
220 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q2 2017.

Based on Putnam Investments's 13F filing for Q2 2017, filed 14 Aug 2017.